| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.38 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.32 | 2e-20 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.28 | 2e-17 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.28 | 4e-16 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.28 | 7e-16 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.26 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-15 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-12 |